Manulife (Manufacturers Life Insurance)’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-2,306
Closed -$165K 4149
2018
Q2
$165K Buy
2,306
+78
+4% +$5.51K ﹤0.01% 3256
2018
Q1
$137K Buy
2,228
+129
+6% +$11.3K ﹤0.01% 3295
2017
Q4
$264K Buy
2,099
+57
+3% +$7.3K ﹤0.01% 2807
2017
Q3
$279K Buy
2,042
+475
+30% +$63.5K ﹤0.01% 2714
2017
Q2
$224K Sell
1,567
-9
-0.6% -$1.39K ﹤0.01% 2916
2017
Q1
$290K Buy
1,576
+151
+11% +$16.9K ﹤0.01% 2567
2016
Q4
$115K Buy
1,425
+4
+0.3% +$316 ﹤0.01% 3165
2016
Q3
$109K Hold
1,421
﹤0.01% 3175
2016
Q2
$122K Buy
1,421
+159
+13% +$14.6K ﹤0.01% 3121
2016
Q1
$111K Buy
1,262
+58
+5% +$5.79K ﹤0.01% 2998
2015
Q4
$242 Buy
1,204
+26
+2% +$5.19K ﹤0.01% 2508
2015
Q3
$176 Buy
1,178
+38
+3% +$27.9K ﹤0.01% 2754
2015
Q2
$1.08K Buy
1,140
+288
+34% +$235K ﹤0.01% 1642
2015
Q1
$624 Buy
852
+30
+4% +$22.5K ﹤0.01% 1966
2014
Q4
$653 Buy
822
+62
+8% +$33.4K ﹤0.01% 1831
2014
Q3
$303 Sell
760
-8
-1% -$2.14K ﹤0.01% 2333
2014
Q2
$207K Buy
768
+181
+31% +$38.8K ﹤0.01% 2690
2014
Q1
$128 Buy
587
+102
+21% +$28.4K ﹤0.01% 2969
2013
Q4
$131 Buy
+485
New +$116K ﹤0.01% 2961

Other funds holding TTPH

Manulife (Manufacturers Life Insurance)'s TTPH Position: Q3 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2018, closing a stake of 2,306 shares — an estimated $165K sold.

Manulife (Manufacturers Life Insurance) first reported a position in TTPH in Q4 2013 and held it in 19 quarters. The position peaked at $290K in Q1 2017. 92 funds tracked by Wall St. Rank hold TTPH as of Q3 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 2,306 Tetraphase Pharmaceuticals, Inc. shares in Q3 2018, an estimated $165K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2013 and held it in 19 quarters.
  • Manulife (Manufacturers Life Insurance)'s Tetraphase Pharmaceuticals, Inc. position peaked at $290K in Q1 2017.
  • 92 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2018, filed 14 Nov 2018.